Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury
Authors:
Open Access
- 1 March 2022
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (3) , e220625
Abstract
Tranexamic acid is a widely available and low-cost medication to limit and manage hemorrhage. Tranexamic acid is indicated for menorrhagia and bleeding in patients with hemophilia1 but also commonly administered off-label for bleeding related to cardiac surgery, orthopedic surgery, and traumatic injuries.1 Many studies2 have sought to confirm or refute the hypothesis that tranexamic acid improves morbidity and mortality among the severely injured. In 2020, the results from 2 new randomized clinical trials (RCTs) on tranexamic acid in trauma3,4 were published. The present work was performed to provide an updated, high-quality systematic review and meta-analysis on the use of tranexamic acid in patients with trauma.Keywords
This publication has 52 references indexed in Scilit:
- Tranexamic Acid Use in Severely Injured Civilian Patients and the Effects on OutcomesAnnals of Surgery, 2015
- Statistical methods for meta‐analyses including information from studies without any events—add nothing to nothing and succeed neverthelessStatistics in Medicine, 2014
- Do all trauma patients benefit from tranexamic acid?Journal of Trauma and Acute Care Surgery, 2014
- Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trialBMC Emergency Medicine, 2013
- Trauma and tranexamic acidMedical Journal of Australia, 2013
- Consensus-based recommendations for investigating clinical heterogeneity in systematic reviewsBMC Medical Research Methodology, 2013
- Association of Cryoprecipitate and Tranexamic Acid With Improved Survival Following Wartime InjuryJAMA Surgery, 2013
- Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) StudyArchives of Surgery, 2012
- Interpretation of random effects meta-analysesBMJ, 2011
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010